ArticleEuropean journal of obstetrics & gynecology and reproductive biology: X2024

Reply to Letter to Editor from Juan-Enrique Schwarze and colleagues - Critical appraisal on "Determining the cost-effectiveness of follitropin alfa biosimilar compared to follitropin alfa originator in women undergoing fertility treatment in France".

Matthieu Lehmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.